-
Global RET Inhibitors Drug Market Opportunity & Clinical Trials Insight 2026 Published: March, 2021 - Pages: 150 - US$ 2,400.00 COVID-19 update included[CovidUpdated]
-
Carpal Tunnel Syndrome - Global Clinical Trials Review, H1, 2021 Published: March, 2021 - Pages: 135 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Pandemic Influenza - Global Clinical Trials Review, H1, 2021 Published: March, 2021 - Pages: 120 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
IgA Nephropathy (Berger's Disease) - Global Clinical Trials Review, H1, 2021 Published: March, 2021 - Pages: 131 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Epstein-Barr Virus (HHV-4) Infections - Global Clinical Trials Review, H1, 2021 Published: March, 2021 - Pages: 137 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Tachycardia (Tachyarrhythmias) - Global Clinical Trials Review, H1, 2021 Published: March, 2021 - Pages: 207 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Mumps - Global Clinical Trials Review, H1, 2021 Published: March, 2021 - Pages: 93 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Angiosarcoma - Global Clinical Trials Review, H1, 2021 Published: March, 2021 - Pages: 153 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Esophageal Varices - Global Clinical Trials Review, H1, 2021 Published: March, 2021 - Pages: 100 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Fasciitis - Global Clinical Trials Review, H1, 2021 Published: March, 2021 - Pages: 97 - US$ 2,500.00 COVID-19 update included[CovidUpdated]